You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥師幫啓動至多1億元回購,多重利好驅動估值修復

近日,藥師幫(9885.HK)持續釋放積極信號。5月7日公告顯示,公司根據2024年股份回購授權,首次回購合共300,000股股份,總代價約爲210.4萬港元,平均每股7.0147港元,回購股份將被註銷。公司擬於2025年10月31日前動用最多1億元港幣於公開市場回購股份。回購計劃高效推進,展現公司對於自身業績和未來市場的正面預期。管理層也同步增持提振信心,執行董事陳飛於4月連續增持50萬股(約316.7萬港元),持股比例升至1.14%。

近期,公司基本面改善勢頭顯著:2024年業績報告顯示全年營收179.04億元,同比增長5.5%;經調淨利潤1.57億元,同比增20.1%,首次實現全年盈利。這表明其前期在數字化建設與供應鏈優化方面的投入,已進入價值兌現階段。公司現金流健康度良好,存貨週轉天數僅31天,現金循環週期爲-28.9天,實現高效的庫存與現金管理,堪稱“現金牛”。

經營穩定、現金流充裕的優勢,疊加目前被嚴重低估的市值水平,使藥師幫具備明顯的“菸蒂股”特徵,吸引了公募基金的重點關注。對比其他港股醫療科技公司,藥師幫的估值倍數明顯偏低,當前市值遠低於企業內在價值。有分析師認爲,“菸蒂股”的預期空間主要體現在短期估值修復:當市場情緒改善或行業景氣度回升時,股票價格將向內在價值迴歸,而其中的優質企業通過經營改善,也更有機會實現長期價值的提升。

隨着國內政策持續推動基層醫療資源配置優化,藥師幫等具備數字化先發優勢的企業將有望進入發展快車道。藥師幫的回購增持、業績兌現將與資金面改善形成合力,“基本面向上+估值窪地”的稀缺屬性愈加明顯,中長線佈局的機會點或已出現。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account